ConductScience.org, home

Comparison · NCT04122443-81a30580

Ibuprofen and Then Acetaminophen (Stage 2) vs Ibuprofen and Then Oxycodone/Acetaminophen (Stage 2): Medication-related Adverse Events

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Ibuprofen and Then Acetaminophen (Stage 2) vs Ibuprofen and Then Oxycodone/Acetaminophen (Stage 2): Medication-related Adverse Events. Trial comparisons, record NCT04122443-81a30580. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT04122443-81a30580

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.09460.04660.183wilson
Risk in group 20.3420.2450.454wilson
Risk difference, group 1 minus group 2-0.248-0.369-0.117newcombe hybrid score
Risk ratio, group 1 over group 20.2770.1280.598log
Odds ratio, group 1 over group 20.2010.08080.5log
Number needed to treat, for one fewer participant with the outcome on Ibuprofen and Then Acetaminophen (Stage 2) than on Ibuprofen and Then Oxycodone/Acetaminophen (Stage 2)4.042.718.57from the risk difference interval

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Ibuprofen and Then Acetaminophen (Stage 2)Ibuprofen - 600mg PO (Stage 1, Open label)~Acetaminophen alone (Stage 2, Double blinded)~Acetaminophen: Acetaminophen 650mg PO774OG000
Group 2Ibuprofen and Then Oxycodone/Acetaminophen (Stage 2)Ibuprofen - 600mg PO (Stage 1, Open label)~Oxycodone + Acetaminophen (Stage 2, Double blinded)~Acetaminophen: Acetaminophen 650mg PO~Oxycodone: Oxycodone 10mg PO2676OG001

Outcome

Type
SECONDARY
Title
Medication-related Adverse Events
Description
Stage 1 (Open label): No Outcome Measures assessed~Stage 2 (Double blinded): The number of participants demonstrating medication-related adverse events was tabulated by treatment arm/group.
Time frame
2 hours following treatment
Population
Responses for 3 participants in the 'Acetaminophen' arm and 1 participant in the 'Oxycodone + Acetaminophen' arm were unavailable.

Source ClinicalTrials.gov

Trial

Title
Acetaminophen (APAP) +/- Oxycodone
NCT number
NCT04122443
Phases
PHASE4
Conditions
Musculoskeletal Pain
Interventions
Acetaminophen, Oxycodone
Lead sponsor
Montefiore Medical Center
Results first posted
2024-02-28

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT04122443-81a30580